Hanyang University Guri Hospital Trials

Hanyang University Guri Hospital	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Lee

NCT05509868: Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South Korea

Recruiting

225

RoW

PBK_L1704 0.35mg, PBK_L1704 0.5mg, Placebo

Pharmbio Korea Co., Ltd.

Acute Pain

12/22

STAMP, NCT05529056: Study of Atropine Therapeutic Effect on Myopic Progression

Recruiting

472

RoW

Atropine Sulfate 01, LPTAT01, Atropine Sulfate 02, LPTAT02, Atropine Sulfate 03, LPTAT03, Placebo, LPTAT04

LitePharmTech Co., Ltd.

Myopia, Children

06/23

12/23

NCT05128344 / 2021-003015-26: A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

Withdrawn

150

Europe, US, RoW

AMZ002 injectable solution, 0.5mg/mL, Vigabatrin, oral

Amzell

Spasms, Infantile

06/25

12/25

PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Active, not recruiting

9541

Europe, Canada, Japan, US, RoW

Obicetrapib, Placebo

NewAmsterdam Pharma, Monash University

Atherosclerotic Cardiovascular Disease

11/26

MajesTEC-4, NCT05243797 / 2021-002531-27: Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Recruiting

1594

Europe, Canada, US, RoW

Teclistamab, JNJ-64007957, Lenalidomide

Stichting European Myeloma Network, Janssen Pharmaceutica

Multiple Myeloma

04/28

04/32

CARTITUDE-6, NCT05257083 / 2021-003284-10: A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

Recruiting

750

Europe, Canada, Japan, US, RoW

Daratumumab, Bortezomib, Lenalidomide, Dexamethasone, Cilta-cel, JNJ-68284528, Cyclophosphamide, Fludarabine

Stichting European Myeloma Network, Janssen Research & Development, LLC

Multiple Myeloma

06/33

08/40

JACKPOT8, NCT04105010: Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL

Completed

171

US, RoW

AZD4205

Dizal Pharmaceuticals

Relapsed or Refractory Peripheral T Cell Lymphoma

10/23

02/24

NCT05733624: Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Completed

116

RoW

SCAI-001 0.01% eyedrop, Cyclosporine 0.01%, SCAI-001 0.02% eyedrop, Cyclosporine 0.02%, Restasis 0.05% eyedrop, Cyclosporine 0.05%

SCAI Therapeutics

Dry Eye Syndromes

08/23

02/24

PLATINUM, NCT05338619: A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy

Recruiting

RoW

Lazertinib, LECLAZA

Sung Yong Lee, Yuhan Corporation

Non-small Cell Lung Cancer Stage III, EGFR Positive Non-small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer

03/26

WU-KONG1, NCT03974022: Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer with EGFR or HER2 Mutation

Active, not recruiting

1/2

315

Europe, Canada, Japan, US, RoW

Sunvozertinib, DZD9008

Dizal Pharmaceuticals

Non-Small Cell Lung Cancer

07/24

07/25

NCT04746573: Effect of Natrox Oxygen Wound Therapy on Non-healing Wounds and Implication of Remote Monitoring and Telehealth for Management in the Home.

Completed

N/A

Natrox Topical Oxygen Therapy

Inotec AMD Limited, Salem VA Medical Center

Non-healing Wounds

05/22

JS-CT-2024-02, NCT06591221: The Effectiveness of Chuna Maintenance Therapy for Chronic Bothersome Neck Pain

Recruiting

N/A

250

RoW

Chuna Maintenance Therapy

Jaseng Medical Foundation

Neck Pain, Chronic Pain

12/25

ATEC.EOS-2402, NCT06659055: Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXA

Recruiting

N/A

214

DXA Imaging, EOSedge imaging

Alphatec Spine, Inc.

Healthy, Indicated for EOSedge Imaging

02/25

03/25

JS-CT-2024-04, NCT06572579: A Pilot Registry for Ultrasound-guided Pharmacopuncture

Recruiting

N/A

RoW

Ultrasound-guided pharmacopuncture treatment

Jaseng Medical Foundation

Neck Pain, Back Pain

12/25

NCT04701684: WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

Recruiting

N/A

564

Europe, US, RoW

Direct to Angio Suite (DTAS) Philips' CBCT triage, Conventional CT/MR triage

Philips Clinical & Medical Affairs Global

Stroke, Acute

12/25

NCT06734858: Pivotal Trial of SAT-014 for Trauma and Stressor-Related Disorder Symptoms

Recruiting

N/A

110

RoW

SAT014, Control

S-Alpha Therapeutics, Inc.

Post-traumatic Stress Disorder, Adjustment Disorders

07/25

10/25

SAT001-KP-003, NCT06742268: Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children

Recruiting

N/A

RoW

Single vision spectacles

S-Alpha Therapeutics, Inc.

Myopia

10/25

07/26

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Lee

NCT05509868: Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South Korea

Recruiting

225

RoW

PBK_L1704 0.35mg, PBK_L1704 0.5mg, Placebo

Pharmbio Korea Co., Ltd.

Acute Pain

12/22

STAMP, NCT05529056: Study of Atropine Therapeutic Effect on Myopic Progression

Recruiting

472

RoW

Atropine Sulfate 01, LPTAT01, Atropine Sulfate 02, LPTAT02, Atropine Sulfate 03, LPTAT03, Placebo, LPTAT04

LitePharmTech Co., Ltd.

Myopia, Children

06/23

12/23

NCT05128344 / 2021-003015-26: A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

Withdrawn

150

Europe, US, RoW

AMZ002 injectable solution, 0.5mg/mL, Vigabatrin, oral

Amzell

Spasms, Infantile

06/25

12/25

PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Active, not recruiting

9541

Europe, Canada, Japan, US, RoW

Obicetrapib, Placebo

NewAmsterdam Pharma, Monash University

Atherosclerotic Cardiovascular Disease

11/26

Recruiting

1594

Europe, Canada, US, RoW

Teclistamab, JNJ-64007957, Lenalidomide

Stichting European Myeloma Network, Janssen Pharmaceutica

Multiple Myeloma

04/28

04/32

Recruiting

750

Europe, Canada, Japan, US, RoW

Daratumumab, Bortezomib, Lenalidomide, Dexamethasone, Cilta-cel, JNJ-68284528, Cyclophosphamide, Fludarabine

Stichting European Myeloma Network, Janssen Research & Development, LLC

Multiple Myeloma

06/33

08/40

JACKPOT8, NCT04105010: Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL

Completed

171

US, RoW

AZD4205

Dizal Pharmaceuticals

Relapsed or Refractory Peripheral T Cell Lymphoma

10/23

02/24

NCT05733624: Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Completed

116

RoW

SCAI-001 0.01% eyedrop, Cyclosporine 0.01%, SCAI-001 0.02% eyedrop, Cyclosporine 0.02%, Restasis 0.05% eyedrop, Cyclosporine 0.05%

SCAI Therapeutics

Dry Eye Syndromes

08/23

02/24

Recruiting

RoW

Lazertinib, LECLAZA

Sung Yong Lee, Yuhan Corporation

Non-small Cell Lung Cancer Stage III, EGFR Positive Non-small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer

03/26

WU-KONG1, NCT03974022: Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer with EGFR or HER2 Mutation

Active, not recruiting

1/2

315

Europe, Canada, Japan, US, RoW

Sunvozertinib, DZD9008

Dizal Pharmaceuticals

Non-Small Cell Lung Cancer

07/24

07/25

NCT04746573: Effect of Natrox Oxygen Wound Therapy on Non-healing Wounds and Implication of Remote Monitoring and Telehealth for Management in the Home.

Completed

N/A

Natrox Topical Oxygen Therapy

Inotec AMD Limited, Salem VA Medical Center

Non-healing Wounds

05/22

JS-CT-2024-02, NCT06591221: The Effectiveness of Chuna Maintenance Therapy for Chronic Bothersome Neck Pain

Recruiting

N/A

250

RoW

Chuna Maintenance Therapy

Jaseng Medical Foundation

Neck Pain, Chronic Pain

12/25

ATEC.EOS-2402, NCT06659055: Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXA

Recruiting

N/A

214

DXA Imaging, EOSedge imaging

Alphatec Spine, Inc.

Healthy, Indicated for EOSedge Imaging

02/25

03/25

JS-CT-2024-04, NCT06572579: A Pilot Registry for Ultrasound-guided Pharmacopuncture

Recruiting

N/A

RoW

Ultrasound-guided pharmacopuncture treatment

Jaseng Medical Foundation

Neck Pain, Back Pain

12/25

NCT04701684: WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

Recruiting

N/A

564

Europe, US, RoW

Direct to Angio Suite (DTAS) Philips' CBCT triage, Conventional CT/MR triage

Philips Clinical & Medical Affairs Global

Stroke, Acute

12/25

NCT06734858: Pivotal Trial of SAT-014 for Trauma and Stressor-Related Disorder Symptoms

Recruiting

N/A

110

RoW

SAT014, Control

S-Alpha Therapeutics, Inc.

Post-traumatic Stress Disorder, Adjustment Disorders

07/25

10/25

SAT001-KP-003, NCT06742268: Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children

Recruiting

N/A

RoW

Single vision spectacles

S-Alpha Therapeutics, Inc.

Myopia

10/25

07/26



	Diseases Companies Products Productz Mechanisms of Action Sites